Charter Oak Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-447
Closed -$15K 639
2022
Q2
$15K Sell
447
-30
-6% -$1.05K ﹤0.01% 532
2022
Q1
$17K Sell
477
-100
-17% -$3.42K ﹤0.01% 548
2021
Q4
$18K Sell
577
-73
-11% -$2.38K ﹤0.01% 528
2021
Q3
$21K Sell
650
-508
-44% -$16.3K ﹤0.01% 451
2021
Q2
$35K Buy
+1,158
New +$38.1K ﹤0.01% 363

Other funds holding OGN

Charter Oak Capital Management's OGN Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 447 shares — an estimated $15K sold.

Charter Oak Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $35K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 447 Organon & Co shares in Q3 2022, an estimated $15K.
  • Charter Oak Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Charter Oak Capital Management's Organon & Co position peaked at $35K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.